Latest news with #MSEL
Business Standard
2 days ago
- Business
- Business Standard
Sustaining Operational Excellence and Financial Strength, Nava Advances on Strategic Growth Projects
PRNewswire Hyderabad (Telangana) [India], August 14: NAVA Limited, a diversified Indian multinational conglomerate operating across Metals, Mining, Energy, Commercial Agriculture, and Healthcare, today announced its financial results for the quarter ended June 30, 2025. The Company reported its highest-ever quarterly PBT, alongside steady progress on its strategic initiatives in India and overseas. Key Business Highlights Consolidated Q1 FY26: * Total income: ₹1,232.6 crore, up 16.7% quarter-on-quarter (QoQ) and marginally lower by 2.0% year-on-year (YoY). * Net profit: ₹399.1 crore - up 31.8% QoQ and lower by 10.5% YoY. * Average tax rate is higher, as profits from the power division of MEL are subject to tax at 15% from Q1 FY26. * Maamba Energy Limited (MEL): Received arrears of USD 75.0 million, reducing outstanding receivables to USD 85.5 million. * Sponsors received maiden dividend from MEL, with Nava group receiving USD 32.5 million as its share. * Projects: MEL's Phase II 300 MW expansion and MSEL's 100 MW solar project in Zambia are on track for scheduled commissioning in Q2 of FY 2027. Business Performance (Q1 FY26): * Metals: Ferro alloys sales volume rose to 33,130 MT from 25,116 MT YoY, with further improved realizations in Ferro Silicon exports. * Energy: Strong operational performance across India and Zambia; MEL sustained high PLF at 95.2%. Indian power plants also operated at an overall average PLF of 86.6% during the quarter. * Mining: Continued stable operations and profitability. * Commercial Agriculture: Avocado plantations are on track for first commercial harvest (~250 MT) in Nov/Dec 2025; Sugar cane plantation for the integrated sugar project has commenced with key project management being undertaken by group companies and the 20 MW Co-generation power plant being set for relocation to Zambia as part of this Project.. The capex outlay for the sugar project is now estimated to be USD 200.0 Mn, taking into account evaluated capital commitments. Standalone Q1 FY26: * Total revenue: ₹572.7 crore, up 8.4% QoQ and 5.0% YoY including dividend of USD 4.0 Mn from Nava Global Pte Ltd (formerly Nava Bharat (Singapore) Pte Ltd). * PAT: ₹141.0 crore, up 45.2% QoQ and 7.6% YoY. Strategic Updates: * Received approvals for the segregation two captive power plants in Telangana and Odisha as IPPs. The operationalization of this segregation is envisaged in Q3/Q4 resulting in better productivity in energy division thereafter. * Nava Global will directly hold 65% equity in MSEL in a JV with ZCCM-IH (35%) to obtain a higher and independent enterprise value. * It has been decided to amalgamate the intermediate holding company on commercial agriculture with Nava Global making the latter a investment hub for all overseas operating ventures in metals, mining, energy and commercial agriculture Commenting on the performance, Managing Director and CEO, Ashwin Devineni, said: "We are pleased to report our highest-ever quarterly PBT, driven by strong operations across our energy portfolio and improved realizations in the metals business. The 50% tax concession regime applicable to the power division under MEL impacted the PAT for the quarter. The resolution of a substantial portion of MEL's receivables and the receipt of its maiden dividend are significant steps in further strengthening our cash position. Our strategic projects -- from renewable energy in Zambia to commercial agriculture in Africa -- are progressing as planned, positioning us for sustainable growth. The planned conversion of our captive power assets to IPPs will further enhance operational efficiency. We remain committed to disciplined capital allocation, operational excellence, and the timely execution of our growth plans to create enduring value for all stakeholders." About Nava Limited Founded in 1972, Nava Limited is a publicly listed multinational corporation with interests in metals, energy, mining, healthcare, and commercial agriculture. As one of India's leading ferroalloy producers, Nava also operates Zambia's largest mine-to-mouth power plant. Expanding its global presence, Nava is investing in commercial agriculture in Zambia and in healthcare in Southeast Asia. For more information, please visit Media Contact: Ms. Lisa Rufus G. Phone: +91 91542 40656 Email: lisa.r@ Nava Limited will host a conference call to discuss the quarterly financial results in detail on 14 August 2025 at 1600hrs (IST). Investors and stakeholders are invited to visit the company's website for further details. This document may contain forward-looking statements based on management's beliefs, opinions, and expectations as of the date of this release. Actual results may vary due to risks and uncertainties, and the company does not assume any obligation to update such statements in response to future developments. Please refer to official disclosures for the most accurate and up-to-date information. Logo:
The Wire
2 days ago
- Business
- The Wire
Sustaining Operational Excellence and Financial Strength, Nava Advances on Strategic Growth Projects
HYDERABAD, India, Aug. 14, 2025 /PRNewswire/ -- NAVA Limited, a diversified Indian multinational conglomerate operating across Metals, Mining, Energy, Commercial Agriculture, and Healthcare, today announced its financial results for the quarter ended June 30, 2025. The Company reported its highest-ever quarterly PBT, alongside steady progress on its strategic initiatives in India and overseas. Key Business Highlights Consolidated Q1 FY26: • Total income: ₹1,232.6 crore, up 16.7% quarter-on-quarter (QoQ) and marginally lower by 2.0% year-on-year (YoY). • Net profit: ₹399.1 crore – up 31.8% QoQ and lower by 10.5% YoY. • Average tax rate is higher, as profits from the power division of MEL are subject to tax at 15% from Q1 FY26. • Maamba Energy Limited (MEL): Received arrears of USD 75.0 million, reducing outstanding receivables to USD 85.5 million. • Sponsors received maiden dividend from MEL, with Nava group receiving USD 32.5 million as its share. • Projects: MEL's Phase II 300 MW expansion and MSEL's 100 MW solar project in Zambia are on track for scheduled commissioning in Q2 of FY 2027. Business Performance (Q1 FY26): • Metals: Ferro alloys sales volume rose to 33,130 MT from 25,116 MT YoY, with further improved realizations in Ferro Silicon exports. • Energy: Strong operational performance across India and Zambia; MEL sustained high PLF at 95.2%. Indian power plants also operated at an overall average PLF of 86.6% during the quarter. • Mining: Continued stable operations and profitability. • Commercial Agriculture: Avocado plantations are on track for first commercial harvest (~250 MT) in Nov/Dec 2025; Sugar cane plantation for the integrated sugar project has commenced with key project management being undertaken by group companies and the 20 MW Co-generation power plant being set for relocation to Zambia as part of this Project.. The capex outlay for the sugar project is now estimated to be USD 200.0 Mn, taking into account evaluated capital commitments. Standalone Q1 FY26: • Total revenue: ₹572.7 crore, up 8.4% QoQ and 5.0% YoY including dividend of USD 4.0 Mn from Nava Global Pte Ltd (formerly Nava Bharat (Singapore) Pte Ltd). • PAT: ₹141.0 crore, up 45.2% QoQ and 7.6% YoY. Strategic Updates: • Received approvals for the segregation two captive power plants in Telangana and Odisha as IPPs. The operationalization of this segregation is envisaged in Q3/Q4 resulting in better productivity in energy division thereafter. • Nava Global will directly hold 65% equity in MSEL in a JV with ZCCM-IH (35%) to obtain a higher and independent enterprise value. • It has been decided to amalgamate the intermediate holding company on commercial agriculture with Nava Global making the latter a investment hub for all overseas operating ventures in metals, mining, energy and commercial agriculture Commenting on the performance, Managing Director and CEO, Ashwin Devineni, said: "We are pleased to report our highest-ever quarterly PBT, driven by strong operations across our energy portfolio and improved realizations in the metals business. The 50% tax concession regime applicable to the power division under MEL impacted the PAT for the quarter. The resolution of a substantial portion of MEL's receivables and the receipt of its maiden dividend are significant steps in further strengthening our cash position. Our strategic projects — from renewable energy in Zambia to commercial agriculture in Africa — are progressing as planned, positioning us for sustainable growth. The planned conversion of our captive power assets to IPPs will further enhance operational efficiency. We remain committed to disciplined capital allocation, operational excellence, and the timely execution of our growth plans to create enduring value for all stakeholders." Quantitative Table of Operational Data (Sales Qty): Quarter FY Jun-25 Jun-24 YoY% Mar-25 FY 2025 Metals (MT) Silico Manganese 29,789 22,989 29.6 % 37,645 94,686 Ferro Silicon 3,341 2,127 57.1 % 4,682 12,162 Energy (MUs) Nava - Merchant Sales 288 302 -4.6 % 163 768 Nava – Captive Consumption 169 127 33.1 % 172 632 NBEIL 236 257 -8.2 % 200 783 MEL 561 588 -4.6 % 464 2,109 Mining (MT 000's) MEL – Coal 118 125 -5.6 % 101 443 About Nava Limited Founded in 1972, Nava Limited is a publicly listed multinational corporation with interests in metals, energy, mining, healthcare, and commercial agriculture. As one of India's leading ferroalloy producers, Nava also operates Zambia's largest mine-to-mouth power plant. Expanding its global presence, Nava is investing in commercial agriculture in Zambia and in healthcare in Southeast Asia. For more information, please visit Media Contact: Ms. Lisa Rufus G. Phone: 91 91542 40656 Email: lisa.r@ Nava Limited will host a conference call to discuss the quarterly financial results in detail on 14 August 2025 at 1600hrs (IST). Investors and stakeholders are invited to visit the company's website for further details. This document may contain forward-looking statements based on management's beliefs, opinions, and expectations as of the date of this release. Actual results may vary due to risks and uncertainties, and the company does not assume any obligation to update such statements in response to future developments. Please refer to official disclosures for the most accurate and up-to-date information. (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.). PTI
Medscape
04-06-2025
- General
- Medscape
Biliary Atresia Linked to Autism and Neurodevelopment Delays
Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment. METHODOLOGY: Researchers conducted a single-centre observational study to examine general and autism-related neurodevelopment in infants with BA. Surveys on neurodevelopment were completed by 107 parents of children with BA (mean age, 7.8 years; range, 7 months to 12 years; 50% post-transplant). A total of 50 infants with BA younger than 5 years (median age, 2.3 years) were compared with the reference group of 93 age- and sex-matched infants, comprising 50 with a low likelihood (no neurodevelopmental risk) and 43 with a high likelihood (having a first-degree relative with autism and/or attention-deficit/hyperactivity disorder) for neurodevelopmental conditions. General neurodevelopment was assessed using the Mullen Scales of Early Learning (MSEL) and Vineland Adaptive Behavior Scale (VABS); autism-related behaviours were evaluated using the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2). Primary objectives were to compare general neurodevelopmental outcomes between infants with BA and two reference cohorts and to examine the relationship of neurodevelopment to key disease-related factors. TAKEAWAY: Neurodevelopmental concerns were reported by 37% of parents in their child with BA, with 47% requiring at least one support service (most commonly speech and language therapy [20%]), and independently noted by professionals in 28% of cases. Boys with BA were disproportionately affected, with 69% of them scored above the cutoff for autism (t(18) = 3.44; P < .001). < .001). Children with BA showed significantly lower cognitive and adaptive functioning than both low- and high-likelihood reference groups (VABS: F = 18.26; MSEL: F = 9.981; P < .001 for both). < .001 for both). Earlier Kasai surgery ( P = .047) and jaundice clearance at 1 month post-surgery ( P = .012) were significantly associated with better general neurodevelopmental outcomes (F = 2.428; P = .042), but not with the presence of autism-related traits. IN PRACTICE: "High levels of neurodevelopmental difficulties in children with BA reveal a need for greater awareness and enhanced surveillance. That early identification and treatment of BA is linked to better general neurodevelopmental outcome and encourages proactive management," the authors wrote. SOURCE: This study was led by M. Earl, PhD, Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England. It was published online on May 28, 2025, in The Journal of Pediatrics . LIMITATIONS: This study was limited by statistical power and generalisability for subgroup analyses because of the modest sample size. The cross-sectional design captured a snapshot of neurodevelopment but did not account for potential worsening over time. Pandemic-related constraints prevented ADOS-2 assessments in nine eligible infants, potentially underestimating the prevalence of autism traits. DISCLOSURES: This study received funding from MowatLabs, King's College Hospital, National Institute for Health and Care Research Maudsley Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust, and King's College London. The authors declared having no conflicts of interest.
